0001950047-24-002031.txt : 20240307 0001950047-24-002031.hdr.sgml : 20240307 20240307162925 ACCESSION NUMBER: 0001950047-24-002031 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Neurogene Inc. CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980542593 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 24730564 BUSINESS ADDRESS: STREET 1: 535 W 24TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: (877) 237-5020 MAIL ADDRESS: STREET 1: 535 W 24TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 FORMER COMPANY: FORMER CONFORMED NAME: Neoleukin Therapeutics, Inc. DATE OF NAME CHANGE: 20190812 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC DATE OF NAME CHANGE: 20140128 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Babler Martin CENTRAL INDEX KEY: 0001435618 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O INFINITY PHARMACEUTICALS, INC. STREET 2: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001435618 XXXXXXXX LIVE 0001404644 NEUROGENE INC. 001-36327 535 W 24th Street 5th Floor New York NY 10011 (877) 237-5020 MARTIN BABLER Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

2500 98234.25 9397901 03/07/2024 NASDAQ Common 03/07/2024 Stock Option Exercise Issuer N 2500 03/07/2024 Cash Y 03/07/2024 /s/ Martin Babler